Respiratory infection test kit HWTS-RT058A

SARS-COV-2influenza Ainfluenza B

This kit can be used to qualitatively detect the nucleic acid of SARS-CoV-2, influenza A virus, influenza B virus, adenovirus, mycoplasma pneumoniae and respiratory syncytial virus in vitro. The nucleic acid is extracted from a throat swab sample from human suspected of being infected with SARS-CoV-2, influenza A virus, influenza B virus, adenovirus, Mycoplasma pneumonia or respiratory syncytial virus. The kit can be used to qualitatively detect the nucleic acid of SARS-CoV-2, influenza A virus, influenza B virus, adenovirus, mycoplasma pneumoniae and respiratory syncytial virus from throat swabs suspected pneumonia cases, suspected cluster patients and other patients who need to diagnose or differentially diagnose infections. For screening of suspected patients: the multiple-pathogen détection kit greatly improves the détection rate, facilitâtes the détection of mixed infections, and may be applied for screening of sudden infectious diseases with new pathogens such as influenza; For treatment of confirmed patients: differential diagnosis can help physicians clearly determine the pathogen type and select the appropriate therapy. The overuse of antibiotics can be effectively decreased with the timely selection of appropriate therapies; For etiological investigation: differential diagnosis provides a solid base for the Center for Disease Control and Prévention (CDC) to carry out well-informed epidemiological investigations. Based on these evidences, CDC experts can develop anti-epidemic measures and accurately break the chain of transmission to eliminate potential outbreaks.